Synthetic biology platform for enhancing microbial natural product yields
Terra Bioforge has developed a synthetic biology platform to enhance the production of microbial natural products. By utilizing advanced synbio tools, they can capture, clone, and overexpress large biosynthetic gene clusters, significantly improving compound yields and reducing development time.
Overview
Terra Bioforge has created an innovative synthetic biology platform that addresses the challenges associated with developing microbial natural products. Traditional methods are often slow and yield low titers, making commercialization impractical. This platform leverages synthetic biology tools to capture, clone, and overexpress large biosynthetic gene clusters (up to 150 kb) from bacteria and fungi, enabling the rapid production of valuable small molecules. This approach can potentially reduce development times from years to months and improve compound yields by 10-100 fold.
Technical specifications
Core Technologies:
- Advanced genetic engineering tools for capturing and modifying entire gene pathways.
- Data science, microbial genomics, metabolomics, and bioinformatics for pathway analysis and optimization.
- Promoter engineering and gene knockout techniques to optimize biosynthetic pathways.
Applications:
- Pharmaceutical and agricultural compound production.
- Deorphaning pathways and producing cryptic and novel compounds.
Key Benefits:
- Significant reduction in development time.
- Increased compound yield and titers.
- Ability to handle large and complex biosynthetic gene clusters.
Technology readiness level
This technology has reached a Technology Readiness Level (TRL) of 6, indicating it has been validated in relevant environments. Terra Bioforge has successfully developed over 150 bacterial and fungal compounds, demonstrating the platform's capability and effectiveness. The ongoing validation process includes genome sequencing, pathway analysis, and metabolomic studies to further optimize and refine the technology.
About Terra Bioforge
Terra Bioforge is a synthetic biology company that specializes in microbial strain engineering for the discovery and production of valuable natural products. The company utilizes a proprietary platform that integrates genomics, metabolomics, AI-driven metabolite analysis, and data science to reprogram biosynthetic pathways. Their core technologies include MycoDrive, a genome engineering platform for filamentous fungi, and a Metabologenomics approach that maps microbial molecules to their specific genetic recipes. By offering custom genetic engineering services for bacterial and fungal strains—such as Bacillus, Paenibacillus, and Streptomyces—the company enables the creation of efficient microbial factories for various industrial applications.
These capabilities are designed to help pharmaceutical and agtech partners shorten R&D timelines, increase fermentation efficiency, and reduce production costs for complex chemistries. The company supports projects across human health, animal health, and agriculture, including tasks such as optimizing nutrient utilization, stable fluorescent labeling, and the secretion of bioactive peptides or enzymes. By enabling the scalable production of natural compounds, Terra Bioforge assists customers in bringing products to market faster and more cost-effectively, addressing significant production challenges in the biotechnology and life sciences industries.
delivered to your inbox.